Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 8/20 | 0.69 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.69 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.69 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.69 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.47 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | DHODH | Q02127 | 1/20 | 0.45 |
| ▸ | MAPK9 | P45984 | 3/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 3/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.44 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24252566 | 0.96 | CYP11B2 (0.67) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17808172 | 0.94 | CYP11B2 (0.73) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL19397379 | 0.94 | CYP11B2 (0.73) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL23095117 | 0.94 | CYP11B2 (0.73) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17808057 | 0.94 | CYP11B2 (0.73) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17808063 | 0.92 | CYP11B2 (0.69) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL21725381 | 0.92 | CYP11B2 (0.69) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17945800 | 0.91 | CYP11B2 (0.73) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL21841074 | 0.91 | CYP11B2 (0.73) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17343464 | 0.90 | CYP11B2 (0.63) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220052268-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO., LTD. (JP) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220052268-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLC29A1, NUDT1, SLC29A2 | CYP11B2 3916/4885CYP11B1 4052/4885CYP19A1 2810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.